Related Experiment Video
Updated: Oct 19, 2025

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions
Published on: October 21, 2022
Role of competitive endogenous RNA networks in the pathogenesis of coronary artery disease
Jiebin Zuo1, Mengxi Xu2, Danning Wang1
1Cardiac Surgery and Structural Heart Disease Unit of Cardiovascular Center, The Fifth Affiliated Hospital Sun Yat-sen University, Zhuhai, China.
Background:
The present study aimed to construct a network of competitive endogenous RNAs (ceRNAs) related to the pathogenesis of coronary artery disease (CAD), to provide a novel rationale for CAD treatment.
Methods:
Bioinformatics methods were applied to screen for differentially expressed long non-coding RNAs (DElncRNAs), microRNAs (DEmiRNAs), and mRNAs (DEmRNAs) from the GSE68506, GSE59421, and GSE20129 datasets of the Gene Expression Omnibus (GEO) database. The miRcode database was used to predict lncRNA-binding miRNAs. The miRTarBase, miRDB, and TargetScan databases were used to predict the target genes of these miRNAs. An mRNA-miRNA-lncRNA ceRNA network of CAD was established.
Results:
Between the CAD and normal control groups there were 264 DElncRNAs, 106 DEmiRNAs, and 1,879 DEmRNAs. We screened these differentially expressed gens (DEGs) respectively. There were 21 DElncRNAs, 13 DEmiRNAs, and 143 DEmRNAs in the ceRNA network by using Cytoscape application. The DEmRNAs were involved in the PI3K-Akt signaling pathway and the NF-κB signaling pathway. The key genes in the protein-protein interaction (PPI) network were HSP90AA1, CDKN1A, MCL1, MDM2, MAPK1, ABL1, LYN, CRK, CDK9, and FAS.
Conclusions:
The ceRNA network constructed in this study identified new candidate molecules for the treatment of CAD, providing some more comprehensive and higher-quality choices for the target treatment of CAD.
Insights
This study constructed a competitive endogenous RNA (ceRNA) network to identify novel therapeutic targets for coronary artery disease (CAD). The network revealed key molecules and pathways involved in CAD pathogenesis, offering new treatment strategies.
Area of Science:
- Genomics
- Molecular Biology
- Bioinformatics
Background:
- Coronary artery disease (CAD) poses a significant global health challenge.
- Understanding the molecular mechanisms underlying CAD pathogenesis is crucial for developing effective treatments.
Purpose of the Study:
- To construct a competitive endogenous RNA (ceRNA) network associated with coronary artery disease (CAD).
- To identify novel molecular targets for CAD treatment based on the ceRNA network.
Main Methods:
- Utilized bioinformatics approaches to analyze gene expression datasets (GSE68506, GSE59421, GSE20129) from the Gene Expression Omnibus (GEO) database.
- Employed databases such as miRcode, miRTarBase, miRDB, and TargetScan to predict interactions between long non-coding RNAs (lncRNAs), microRNAs (miRNAs), and messenger RNAs (mRNAs).
- Constructed a comprehensive mRNA-miRNA-lncRNA ceRNA network for CAD using Cytoscape.
Main Results:
- Identified significant numbers of differentially expressed lncRNAs (264), miRNAs (106), and mRNAs (1,879) between CAD and control groups.
- The constructed ceRNA network comprised 21 DElncRNAs, 13 DEmiRNAs, and 143 DEmRNAs.
- Key pathways implicated in CAD pathogenesis include PI3K-Akt and NF-κB signaling. Identified crucial genes within the protein-protein interaction network, including HSP90AA1, CDKN1A, and MCL1.
Conclusions:
- The developed ceRNA network provides novel candidate molecules for CAD treatment.
- Offers a more comprehensive and higher-quality basis for targeted therapeutic strategies in CAD.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Types of RNA
RNA Performs Diverse...

